Peter Johnson
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment 195
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 84
- Immunology top 0.1%
- Reproductive System and Pregnancy 59
- Immune Cell Function and Interaction 40
- Oncology top 0.1%
- CAR-T cell therapy research 44
- Obstetrics and Gynecology top 0.2%
- Pregnancy and preeclampsia studies 36
-
- Monoclonal and Polyclonal Antibodies Research 78
-
- Lung Cancer Treatments and Mutations 54
- Co-authors
- Martin J. GlennieJudith N. BulmerW. Pagé FaulkJohn RadfordGraham PackhamKeith W. CaldecottMark S. CraggRuth R. French
- Journals
- Blood (65 papers)Journal of Clinical Oncology (37 papers)Journal of Reproductive Immunology (28 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Peter Johnson
593 papers receiving 23.0k citations
Hit Papers
Peers
Comparison fields: 5 of 203
- Pathology and Forensic Medicine 7.8k
- Genetics 3.6k
- Immunology 7.0k
- Oncology 7.5k
- Obstetrics and Gynecology 1.6k
Countries citing papers authored by Peter Johnson
This map shows the geographic impact of Peter Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Johnson more than expected).
Fields of papers citing papers by Peter Johnson
This network shows the impact of papers produced by Peter Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Johnson. The network helps show where Peter Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 21 | |
| 6 | 2020 | 3 | |
| 7 | 2018 | 19 | |
| 8 | 2016 | 54 | |
| 9 | 2014 | 106 | |
| 10 | 2013 | 148 | |
| 11 | 2013 | 34 | |
| 12 | 2013 | 119 | |
| 13 | 2013 | 21 | |
| 14 | 2010 | 241 | |
| 15 | Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity in patients with relapsed/refractory follicular or 'aggressive' lymphoma | 2010 | 2 |
| 16 | 2009 | 124 | |
| 17 | 2007 | 8 | |
| 18 | Response-adapted therapy using FDG-PET scanning after initial ABVD: the UK NCRI, Italian and Nordic trial in advanced Hodgkin lymphoma | 2007 | 1 |
| 19 | 2003 | 55 | |
| 20 | 1980 | 8 |
About Peter Johnson
Peter Johnson is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology, having authored 612 papers that have together received 23.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (195 papers), Chronic Lymphocytic Leukemia Research (84 papers), Monoclonal and Polyclonal Antibodies Research (78 papers), Reproductive System and Pregnancy (59 papers), Lung Cancer Treatments and Mutations (54 papers), CAR-T cell therapy research (44 papers), Immune Cell Function and Interaction (40 papers) and Pregnancy and preeclampsia studies (36 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.8k citations), Genetics (3.6k citations) and Immunology (7.0k citations). Peter Johnson has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Martin J. Glennie, Judith N. Bulmer, W. Pagé Faulk, John Radford, Graham Packham, Keith W. Caldecott, Mark S. Cragg, Ruth R. French, Saïd Aoufouchi and Andrew Jack. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Reproductive Immunology, Hematological Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.